Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL31606587 | 1.00 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL28696706 | 0.96 | CA4 (0.36) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL723408 | 0.96 | CA4 (0.36) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL4528375 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL20569310 | 0.92 | — | — | |
| Trifluoroacetic Acid SCHEMBL4342494 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL20569660 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL20571141 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL108536 | 0.92 | — | — | |
| Trifluoroacetic Acid SCHEMBL2828447 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260038834-A1 | REDOX ACTIVE ORGANIC MOLECULES FOR AQUEOUS ZINC-ION CELLS AND BATTERIES | SALIENT ENERGY INC (CA) | 2026-02-05 | — | — | US | claimed |
| US-12435033-B2 | Method and device for preparing adiponitrile | ZHEJIANG NHU COMPANY LTD (CN) | 2025-10-07 | — | — | US | claimed |
| US-20250257095-A1 | METHOD FOR VISIBLE LIGHT-MEDIATED CHEMICAL MODIFICATION OF POLYPEPTIDE AND PROTEIN BASED ON CYSTEINE | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2025-08-14 | — | — | US | claimed |
| EP-4545545-A1 | VISIBLE LIGHT-MEDIATED CYSTEINE-BASED POLYPEPTIDE AND PROTEIN CHEMICAL MODIFICATION METHOD | Shanghai Jiao Tong University (CN) | 2025-04-30 | — | — | EP | claimed |
| CN-119390963-B | Polypeptide ester ether amine random polymer and preparation method and application thereof | 浙江大学 | 2025-04-29 | — | — | CN | claimed |
| CN-119390963-A | Polypeptide ester ether amine random polymer and preparation method and application thereof | 浙江大学 | 2025-02-07 | — | — | CN | claimed |
| CN-119390625-A | Preparation method of 1- (aryl sulfonyl) bicyclo [1.1.0] butane compound | 苏州百灵威超精细材料有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119361862-A | Multiphase wet sand electrolyte, preparation method and application thereof in high Wen Shuiji zinc ion battery | 中国科学院大连化学物理研究所 | 2025-01-24 | — | — | CN | claimed |
| CN-115808462-B | Method for eliminating ammonia gas signal and/or volatile organic amine in ion mobility spectrometry and method for detecting sample | 海能基石技术有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119039115-A | Preparation method of 2, 6-difluoro-4-bromotrifluoromethoxybenzene | 大连奇凯医药科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| US-20060052624-A1 | Making nitrile compounds from ethylenically unsaturated compounds | INVISTA NORTH AMERICA SARL | 2006-03-09 | — | — | US | claimed |
| EP-1284983-B1 | METHOD USED FOR TRANSFORMING THE CARBONYL FUNCTION IN POSITION 4'' OF A CLADINOSE UNIT OF AN AZA MACROLIDE INTO AN AMINE DERIVATIVE | MERIAL SAS (FR) | 2005-11-23 | — | — | EP | claimed |
| EP-0928994-B1 | Toner preparation process | XEROX CORP (US) | 2004-05-06 | — | — | EP | claimed |
| US-20030135016-A1 | Contains a Lewis acid metal salt and a compound having clathrating ability. | TOAGOSEI CO., LTD. | 2003-07-17 | — | — | US | claimed |
| US-6547985-B1 | Adhesive mixture | TOGOSEI CO., LTD. (JP) | 2003-04-15 | — | — | US | claimed |
| US-6133473-A | FREE OF BY-PRODUCTS; PREPARED BY REACTING AN ISOCYANATE WITH A HYDROXYLATED COMPOUND OR OXIME IN THE PRESENCE OF CERTAIN CATALYSTS | ROHM AND HAAS COMPANY (US) | 2000-10-17 | — | — | US | claimed |
| EP-0967199-A1 | Process for preparing carbamates | ROHM AND HAAS COMPANY (US) | 1999-12-29 | — | — | EP | claimed |
| EP-0928994-A2 | Toner preparation processes | Xerox Corporation (US) | 1999-07-14 | — | — | EP | claimed |
| US-5869216-A | LATEX, AGGREGATION, FUSION/COALESCENCE, SURFACE TREATMENT WITH A SALICYLIC ACID OR A CATECHOL | XEROX CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| US-5026799-A | Halogenated aliphatic acids or zinc salts therof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435033-B2 | Method and device for preparing adiponitrile | ADIPOR2, ADIPOR1, ALKBH1 | CA4 3382/4885CA2 3487/4885CA1 4379/4885 |
| US-20260038834-A1 | REDOX ACTIVE ORGANIC MOLECULES FOR AQUEOUS ZINC-ION CELLS AND BATTERIES | SOD3, SOD1, NQO1 | CA4 1251/4885CA2 214/4885CA1 117/4885 |
| US-20060052624-A1 | Making nitrile compounds from ethylenically unsaturated compounds | DBN1, HMOX1, C9 | CA4 1455/4885CA2 2672/4885CA1 1922/4885 |
| US-20250257095-A1 | METHOD FOR VISIBLE LIGHT-MEDIATED CHEMICAL MODIFICATION OF POLYPEPTIDE AND PROTEIN BASED ON CYSTEINE | PTMS, CTH, CISD1 | CA4 2839/4885CA2 3650/4885CA1 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.